Luís Brás Rosario

Prof. Dr. Luís Brás Rosario


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1998 in JACC
Verified
Journal Article
Closed access
LRLuís Brás Rosario
Luís Brás Rosario
LSLynne W. Stevenson
Lynne W. Stevenson
SSScott D. Solomon
Scott D. Solomon
RLRichard T. Lee
Richard T. Lee
SRSharon C. Reimold
Sharon C. Reimold

1 May 2013 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
MVMaurícia Vinhas
Maurícia Vinhas
AAAna Carolina Araújo
Ana Carolina Araújo
SRSónia Ribeiro
Sónia Ribeiro
LRLuís Brás Rosario
Luís Brás Rosario
JBJosé António Belo
José António Belo
Background: In the recent years, the use of Doppler-echocardiography has become a standard non-invasive technique in the analysis of cardiac malformations in genetically modified mice. Therefore, normal values have to be established for the most commonly used inbred strains in whose genetic background those mutations are generated. Here we provide reference values for transthoracic echocardiography measurements in juvenile (3 weeks) and adult (8 weeks) 129/Sv mice. Methods: Echocardiographic measurements were performed using B-mode, M-mode and Doppler-mode in 15 juvenile (3 weeks) and 15 adult (8 weeks) mice, during isoflurane anesthesia. M-mode measurements variability of left ventricle (LV) was determined. Results: Several echocardiographic measurements significantly differ between juvenile and adult mice. Most of these measurements are related with cardiac dimensions. All B-mode measurements were different between juveniles and adults (higher in the adults), except for fractional area change (FAC). Ejection fraction (EF) and fractional shortening (FS), calculated from M-mode parameters, do not differ between juvenile and adult mice. Stroke volume (SV) and cardiac output (CO) were significantly different between juvenile and adult mice. SV was 31.93 ± 8.67 μl in juveniles vs 70.61 ± 24.66 μl in adults, ρ < 0.001. CO was 12.06 ± 4.05 ml/min in juveniles vs 29.71 ± 10.13 ml/min in adults, ρ < 0.001. No difference was found in mitral valve (MV) and tricuspid valve (TV) related parameters between juvenile and adult mice. It was demonstrated that variability of M-mode measurements of LV is minimal. Conclusions: This study suggests that differences in cardiac dimensions, as wells as in pulmonary and aorta outflow parameters, were found between juvenile and adult mice. However, mitral and tricuspid inflow parameters seem to be similar between 3 weeks and 8 weeks mice. The reference values established in this study would contribute as a basis to future studies in post-natal cardiovascular development and diagnosing cardiovascular disorders in genetically modified mouse mutant lines.

21 September 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
LELuis B. Elvas
Luis B. Elvas
MNMiguel Nunes
Miguel Nunes
joao ferreirajoao ferreira
joao ferreira
José Miguel Sales DiasJosé Miguel Sales Dias
José Miguel Sales Dias
LRLuís Brás Rosario
Luís Brás Rosario
Cardiovascular diseases (CVDs) account for a significant portion of global mortality, emphasizing the need for effective strategies. This study focuses on myocardial infarction, pulmonary thromboembolism, and aortic stenosis, aiming to empower medical practitioners with tools for informed decision making and timely interventions. Drawing from data at Hospital Santa Maria, our approach combines exploratory data analysis (EDA) and predictive machine learning (ML) models, guided by the Cross-Industry Standard Process for Data Mining (CRISP-DM) methodology. EDA reveals intricate patterns and relationships specific to cardiovascular diseases. ML models achieve accuracies above 80%, providing a 13 min window to predict myocardial ischemia incidents and intervene proactively. This paper presents a Proof of Concept for real-time data and predictive capabilities in enhancing medical strategies.

15 March 2019 in Circulation Research
Verified
Journal Article
Closed access
PDF file
LSLilian Grigorian Shamagian
Lilian Grigorian Shamagian
RMRosalinda Madonna
Rosalinda Madonna
DTDoris Taylor
Doris Taylor
ACAndreu M. Climent
Andreu M. Climent
FPFelipe Prosper
Felipe Prosper
RBRoberto Bolli
Roberto Bolli
The myocardium consists of numerous cell types embedded in organized layers of ECM (extracellular matrix) and requires an intricate network of blood and lymphatic vessels and nerves to provide nutrients and electrical coupling to the cells. Although much of the focus has been on cardiomyocytes, these cells make up <40% of cells within a healthy adult heart. Therefore, repairing or regenerating cardiac tissue by merely reconstituting cardiomyocytes is a simplistic and ineffective approach. In fact, when an injury occurs, cardiac tissue organization is disrupted at the level of the cells, the tissue architecture, and the coordinated interaction among the cells. Thus, reconstitution of a functional tissue must reestablish electrical and mechanical communication between cardiomyocytes and restore their surrounding environment. It is also essential to restore distinctive myocardial features, such as vascular patency and pump function. In this article, we review the current status, challenges, and future priorities in cardiac regenerative or reparative medicine. In the first part, we provide an overview of our current understanding of heart repair and comment on the main contributors and mechanisms involved in innate regeneration. A brief section is dedicated to the novel concept of rejuvenation or regeneration, which we think may impact future development in the field. The last section describes regenerative therapies, where the most advanced and disruptive strategies used for myocardial repair are discussed. Our recommendations for priority areas in studies of cardiac regeneration or repair are summarized in Tables 1 and 2 .

29 October 2014 in Cells
Verified
Journal Article
Open access
PDF file
MGMargarida Gama-Carvalho
Margarida Gama-Carvalho
JAJorge Andrade
Jorge Andrade
LRLuís Brás Rosario
Luís Brás Rosario
MicroRNAs are post-transcriptional regulators of gene expression that have been shown to be central players in the establishment of cellular programs, often acting as switches that control the choice between proliferation and differentiation during development and in adult tissues. The heart develops from two small patches of cells in the mesoderm, the heart fields, which originate the different cardiac cell types, including cardiomyocytes, vascular smooth muscle and endothelial cells. These progenitors proliferate and differentiate to establish a highly connected three-dimensional structure, involving a robust succession of gene expression programs strongly influenced by microRNAs. Although the mammalian heart has conventionally been viewed as a post-mitotic organ, cardiac cells have recently been shown to display some regenerative potential, which is nonetheless insufficient to regenerate heart lesions, in contrast with other vertebrates like the zebrafish. Both the proliferation of adult cardiac stem cells and the ability of cardiomyocytes to re-enter the cell cycle have been proposed to sustain these regenerative processes. Here we review the role of microRNAs in the control of stem cell and cardiomyocyte dependent cardiac regeneration processes, and discuss potential applications for the treatment of cardiac injury.

21 August 2023 in Systems
Verified
Journal Article
Open access
PDF file
LELuis B. Elvas
Luis B. Elvas
joao ferreirajoao ferreira
joao ferreira
José Miguel Sales DiasJosé Miguel Sales Dias
José Miguel Sales Dias
LRLuís Brás Rosario
Luís Brás Rosario
Data sharing and service reuse in the health sector pose significant privacy and security challenges. The European Commission recognizes health data as a unique and cost-effective resource for research, while the OECD emphasizes the need for privacy-protecting data governance systems. In this paper, we propose a novel approach to health data access in a hospital environment, leveraging homomorphic encryption to ensure privacy and secure sharing of medical data among healthcare entities. Our framework establishes a secure environment that enforces GDPR adoption. We present an Information Sharing Infrastructure (ISI) framework that seamlessly integrates artificial intelligence (AI) capabilities for data analysis. Through our implementation, we demonstrate the ease of applying AI algorithms to treated health data within the ISI environment. Evaluating machine learning models, we achieve high accuracies of 96.88% with logistic regression and 97.62% with random forest. To address privacy concerns, our framework incorporates Data Sharing Agreements (DSAs). Data producers and consumers (prosumers) have the flexibility to express their prefearences for sharing and analytics operations. Data-centric policy enforcement mechanisms ensure compliance and privacy preservation. In summary, our comprehensive framework combines homomorphic encryption, secure data sharing, and AI-driven analytics. By fostering collaboration and knowledge creation in a secure environment, our approach contributes to the advancement of medical research and improves healthcare outcomes. A real case application was implemented between Portuguese hospitals and universities for this data sharing.